Breaking News

Some long Covid patients see symptoms improve; an FDA official's about-face on Chinese cancer drugs

  

 

Daily Recap

'Good, not great': Some long Covid patients see their symptoms improve, but full recovery is elusive

By Elizabeth Cooney

Lissa Gotwals for STAT

Long Covid clinics are helping patients with symptom relief in the absence of a known cause or way to predict who'll develop it.

Read More

STAT+: 'I have a right to change my mind': A top FDA regulator is unapologetic over his about-face on Chinese cancer drugs

By Adam Feuerstein

FDA/Michael J. Ermarth

In an interview with STAT, the FDA's Richard Pazdur acknowledged his view on Chinese cancer drugs had changed.

Read More

STAT+: Health insurers, turning to tech to pinpoint needy patients, risk leaving some behind

By Mohana Ravindranath

Mario Tama/Getty Images

Payers told STAT that predictive models can help connect patients in need with additional support, staving off costlier complications.

Read More

STAT+: Amazon Care announces nationwide expansion of health clinics

By Casey Ross

Adobe

Amazon will open brick-and-mortar health clinics in 20 U.S. cities this year, including New York, Chicago, San Francisco, and Miami.

Read More

STAT+: A San Diego biotech's massive valuation turned heads. Now, mass layoffs raise questions

By Jonathan Wosen and Matthew Herper

Jonathan Wosen/STAT

The layoffs could be seen as yet another reality check for the outsized bets made by some investors on privately held biotechnology firms.

Read More

For burned-out health workers, exhaustion from Covid-19 surges mixes with a sense of betrayal

By Isabella Cueto

STAT

Beneath the bone-deep exhaustion, health care workers burned out amid Covid-19 say they are grappling with another feeling: betrayal. 

Read More

Opinion: Lander's resignation over workplace bullying: The tip of the iceberg of a public health problem

By Pauline Chiou and Cherie Lynn Ramirez

Adobe

Eric Lander's resignation for bullying some White House colleagues is just one snapshot of a national and pervasive public health problem.

Read More

STAT+: The unexpected forces behind thousands of comments about Medicare's limits on a new Alzheimer's drug

By Nicholas Florko

Adobe

Medicare has gotten thousands of comments on its proposal to limit coverage for Aduhelm. But most aren’t from drug makers.

Read More

Tuesday, February 8, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments